Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rena Buckstein

Showing results (41-50 of 133) with videos related to

Pageof 14
Sort By:
Transfusion|October 3, 2024
Reducing unnecessary outpatient group and screen testing at a regional cancer centerHeather VanderMeulen, Akash Gupta, Rena Buckstein, et al.
Leukemia Research|October 8, 2013
Income and outcome in myelodysplastic syndrome: the prognostic impact of SES in a single-payer systemJames T England, Liying Zhang, Rena Buckstein, et al.
British Journal of Haematology|May 17, 2018
Azacitidine in the 'real-world': an evaluation of 1101 higher-risk myelodysplastic syndrome/low blast count acute myeloid leukaemia patients in Ontario, CanadaLee Mozessohn, Matthew C Cheung, Saber Fallahpour, et al.
Leukemia & Lymphoma|June 14, 2011
High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphomaLauren M Gerard, Kevin R Imrie, Joy Mangel, et al.
Scientific Reports|December 4, 2020
Predictors of intensive care unit admission in patients with hematologic malignancyAbi Vijenthira, Nicholas Chiu, Daniel Jacobson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccinesElena Gitelson, Caitlin Hammond, Jenny Mena, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
A Lower Frequency of Spliceosome Mutations Distinguishes Clonal Cytopenias of Undetermined Significance From Low-Risk Myelodysplastic Syndromes, Despite Inherent Similarities in Genomic, Laboratory, and Clinical FeaturesChristina K Ferrone, Amy J M McNaughton, Iran Rashedi, et al.
Leukemia Research|December 24, 2018
The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry studyAbi Vijenthira, Devyani Premkumar, Jeannie Callum, et al.
Transfusion|June 10, 2022
Multi-national survey of transfusion experiences and preferences of patients with myelodysplastic syndromeAbi Vijenthira, Rebecca Starkman, Yulia Lin, et al.
Leukemia & Lymphoma|January 24, 2014
Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosisLee Mozessohn, Matthew C Cheung, Michael Crump, et al.
Pageof 14

Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
Transfusion|October 3, 2024
Reducing unnecessary outpatient group and screen testing at a regional cancer centerHeather VanderMeulen, Akash Gupta, Rena Buckstein, et al.
Leukemia Research|October 8, 2013
Income and outcome in myelodysplastic syndrome: the prognostic impact of SES in a single-payer systemJames T England, Liying Zhang, Rena Buckstein, et al.
British Journal of Haematology|May 17, 2018
Azacitidine in the 'real-world': an evaluation of 1101 higher-risk myelodysplastic syndrome/low blast count acute myeloid leukaemia patients in Ontario, CanadaLee Mozessohn, Matthew C Cheung, Saber Fallahpour, et al.
Leukemia & Lymphoma|June 14, 2011
High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphomaLauren M Gerard, Kevin R Imrie, Joy Mangel, et al.
Scientific Reports|December 4, 2020
Predictors of intensive care unit admission in patients with hematologic malignancyAbi Vijenthira, Nicholas Chiu, Daniel Jacobson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccinesElena Gitelson, Caitlin Hammond, Jenny Mena, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
A Lower Frequency of Spliceosome Mutations Distinguishes Clonal Cytopenias of Undetermined Significance From Low-Risk Myelodysplastic Syndromes, Despite Inherent Similarities in Genomic, Laboratory, and Clinical FeaturesChristina K Ferrone, Amy J M McNaughton, Iran Rashedi, et al.
Leukemia Research|December 24, 2018
The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry studyAbi Vijenthira, Devyani Premkumar, Jeannie Callum, et al.
Transfusion|June 10, 2022
Multi-national survey of transfusion experiences and preferences of patients with myelodysplastic syndromeAbi Vijenthira, Rebecca Starkman, Yulia Lin, et al.
Leukemia & Lymphoma|January 24, 2014
Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosisLee Mozessohn, Matthew C Cheung, Michael Crump, et al.
Pageof 14